Dispensary Care (Oncology)


 * Monitoring of cancer patients is continuous.

Goals

 * Early detection of relapse or recurrence:
 * the risk is usually greatest in the first years after healing;
 * recurrence within one year is usually unfavorable, placing the disease in a group of resistant ones;
 * some tumors are considered chronic diseases and relapse after a long time is not an exception (breast, malignant lymphogranuloma).
 * Detection and treatment of late effects of therapy:
 * sterility, cataract, nephropathy, mental changes, ...
 * Detection of possible duplicate tumors:
 * it may be a greater susceptibility to carcinogenesis or a treatment-induced tumor (tumor in the irradiated area, after alkylation cytostatics, ...).

Recurrence, Relapse

 * Return of the process at the place of disability or in the immediate proximity - local recurrence.
 * Return in distant places - distant recurrence, metastatic process.
 * If it is a systemic disease from the beginning, we prefer to use the word relapse, but there is no exact distinction.
 * It is necessary to distinguish between new relapse and tumor persistence.
 * In terms of prognosis, it is good to divide the relapse into early (within a year) and late.

Related Articles

 * Side effects of cytostatic treatment

Source

 * BENEŠ, Jiří. Studijní materiály [online]. ©2012. [cit. 25. 4. 2012]. < http://jirben2.chytrak.cz/materialy/onko_JB.doc >.